In patients who do not take statins, higher levels of total cholesterol and low-density lipoprotein cholesterol decreased the risk of Parkinson disease for men aged 50 to 69 and women aged 70 to 74, according to a study published in Movement Disorders. Researchers analyzed the data from 261,638 patients' blood serum to establish the relationship between cholesterol levels and Parkinson disease. They took lipid profiles routinely as part of the standard screening and used mean annual levels to establish the cholesterol measurements.
Researchers gauged incidence of Parkinson disease using an antiparkinsonian drug tracer algorithm. The baseline means age for men was 47.1 years and for women was 45.8 years , with an average follow-up time for the study of 7.9 years. At baseline, total cholesterol and low-density lipoprotein cholesterol levels were similar for both sexes, and high-density…
